Related Experiment Video
Updated: Jul 16, 2026

Cytosolic Calcium Measurements in Renal Epithelial Cells by Flow Cytometry
Published on: October 28, 2014
Citrate anticoagulation control by ionized calcium levels does not prevent hemostasis and complement activation
Karel Opatrný1, Pavlína Richtrová, Kamila Polanská
1Department of Internal Medicine I, Charles University Medical School, Alej Svobody 80, 304-60 Pilsen, Czech Republic.
Abstract:
The purpose of this study was to determine whether or not regional citrate anticoagulation (RCA) controlled by ionized calcium (iCa(2+)) would overcome thrombogenicity, prevent hemostasis, and complement activation during hemodialysis (HD). RCA was performed in 10 patients during 10 HD sessions using a polysulfone membrane in an effort to keep iCa(2+) at dialyzer outlet at < or =0.4 mmol/L. Compared to baseline, plasma levels of thrombin-antithrombin III complexes rose significantly at 240 min, and tissue factor and complement C5a component levels at 30 and 240 min of the procedure. Thrombocyte count declined significantly at 30 and 240 min, while activated clotting time (ACT) did not increase significantly, and platelet factor 4 as well as von Willebrand factor levels did not alter significantly. While ACT correlated significantly with some thrombogenicity markers, iCa(2+) did not correlate with ACT, changes in hemostasis, or C5a. We conclude the usually recommended iCa(2+) levels in the HD extracorporeal circuit did not guarantee the complete overcoming of thrombogenicity, prevention of hemostasis, and complement activation.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Continuous Renal Replacement Therapy
Hemodialysis II: Procedure and Complications
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Hemodialysis III: Nursing Management
